Background: Chlamydia pneumoniae is found worldwide, it causes acute respiratory infection, especially atypical pneumonia. High prevalence of past infection with Ch. pneumoniae have been found in developing countries that may has a role in pathogenesis of coronary heart disease. Objective: The present study was sought todetermined the rate of anti-Ch. pneumoniae IgG and IgA antibodies among patients with coronary heart diseases in Diyala province, Iraq. Material and Methods: This study was conducted during the period from November/ 2013 to December/ 2014. 91 Participants were included; 45 patients with coronary heart disease (myocardial infarction, angina, and atherosclerosis) who were chosen according to clinical criteria and 46 apparently healthy individuals as control group. The mean age of the patients was (59.20 ± 11.45) years with an age rang (40-90) years, and for the controls, and the mean age was (35.43 ± 8.67) years with an age rang (32-86) years. Detection of anti-Ch. pneumoniae IgG and IgA antibodies was done by Enzyme-Linked Immunosorbant Assay (Nova Tec immundiagnostica GmbH, Germany). Results: The present results study show that the positivity rate of anti-Ch. pneumoniae IgG antibodies was significantly higher among patients compared to controls (66.67%vs54.35%, P ≤ 0.05). While, the seroprevalence of anti-Ch. pneumoniae IgA antibodies among patients and controls was 24.44%and 13.04% respectively, this results showed that there is a statistically significant association between Chlamydia pneumoniae and CHD, P ≤ 0.05. Conclusion: The presence of anti-Ch. pneumoniae IgG and IgA are significantly associated with CHD patients in Diyala province.